Role of beta-2-microglobulin as a biomarker in very preterm and extremely preterm infants with CNS inflammation.
Albert Batista MuñozStephanie HadleyMarti Iriondo SanzThais Agut QuijanoMarta Camprubí-CamprubíPublished in: PloS one (2019)
In this population, CSF B2M proved to be an effective biomarker to discriminate between patients with CNS infections and other inflammatory processes and those without CNS inflammation.